BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23764709)

  • 21. Late-onset Haemophilus Influenzae endophthalmitis in an immunized child after Baerveldt implant.
    Trzcinka A; Soans FP; Archer SM; Moroi SE
    J AAPOS; 2008 Aug; 12(4):412-4. PubMed ID: 18440257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans.
    Chang Lin JE; Welty D
    Surv Ophthalmol; 2006; 51(5):530; author reply 530-1. PubMed ID: 16950254
    [No Abstract]   [Full Text] [Related]  

  • 23. Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.
    Moshirfar M; Meyer JJ; Espandar L
    J Cataract Refract Surg; 2007 Nov; 33(11):1978-81. PubMed ID: 17964409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycobacterium fortuitum infection masquerading as an orbital mass.
    Ali S; Sivak-Callcott JA; Khakoo R; Williams HJ
    Ophthalmic Plast Reconstr Surg; 2007; 23(4):327-9. PubMed ID: 17667115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycobacterium fortuitum as a cause of peritoneal dialysis catheter port infection. A clinical case and a review of the literature.
    Martínez López AB; Álvarez Blanco O; Ruíz Serrano MJ; Morales San-José MD; Luque de Pablos A
    Nefrologia; 2015; 35(6):584-6. PubMed ID: 26565935
    [No Abstract]   [Full Text] [Related]  

  • 26. Propionibacterium endophthalmitis following Molteno tube repositioning.
    Fanous MM; Cohn RA
    J Glaucoma; 1997 Aug; 6(4):201-2. PubMed ID: 9264297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cluster of Mycobacterium fortuitum prosthetic joint infections.
    Cornelius L; Reddix R; Burchett C; Bond G; Fader R
    J Surg Orthop Adv; 2007; 16(4):196-8. PubMed ID: 18053402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
    McDonald MB; Protzko EE; Brunner LS; Morris TW; Haas W; Paterno MR; Comstock TL; Usner DW
    Ophthalmology; 2009 Sep; 116(9):1615-1623.e1. PubMed ID: 19643483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Knee prosthetic-joint infection due to Mycobacterium fortuitum].
    Lopez Alonso B; Beltrán Rosel A; Pitarch Marco F; López Alonso I
    Enferm Infecc Microbiol Clin; 2016; 34(6):393-4. PubMed ID: 26556596
    [No Abstract]   [Full Text] [Related]  

  • 31. Atypical Mycobacterial Infection Following Upper Eyelid Blepharoplasty.
    Crosswell EG; Leyngold IM
    Ophthalmic Plast Reconstr Surg; 2016; 32(5):e116-8. PubMed ID: 25210873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effectiveness of intraocular delivery of 5-fluoroquinolones for prophylaxis of intraocular infection].
    Boĭko ÉV; Fokina DV; Reĭtuzov VA; Alekperov SI
    Voen Med Zh; 2011 Jul; 332(7):30-5. PubMed ID: 21938899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery.
    Bucci FA; Amico LM; Evans RE
    Eye Contact Lens; 2008 Jan; 34(1):39-42. PubMed ID: 18180682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canaliculitis involving Mycobacterium fortuitum after dacryocystorhinostomy with silicone stenting.
    Elahi E; Su D; Young A
    Can J Ophthalmol; 2011 Jun; 46(3):291-2. PubMed ID: 21784223
    [No Abstract]   [Full Text] [Related]  

  • 35. Infection in breast implants.
    Vinh DC; Embil JM
    Lancet Infect Dis; 2005 Aug; 5(8):462-3; author reply 463. PubMed ID: 16048710
    [No Abstract]   [Full Text] [Related]  

  • 36. [New indications for novel fluoroquinolones: moxifloxacin in the treatment of nosocomial infections].
    Beloborodova NV; Popov DA; Vostrikova TIu; Bachinskaia EN; Kuznetsova ST
    Antibiot Khimioter; 2009; 54(1-2):25-6, 28-30. PubMed ID: 19499714
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
    Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME
    Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nontuberculous Mycobacterial Infection after Removal of the Exposed Hydroxyapatite.
    Song YY; You IC; Ahn M
    Korean J Ophthalmol; 2017 Aug; 31(4):366-367. PubMed ID: 28752699
    [No Abstract]   [Full Text] [Related]  

  • 39. Switch and gain - sequential moxifloxacin monotherapy.
    Stein RA
    Int J Clin Pract; 2013 Sep; 67(9):820-2. PubMed ID: 23952460
    [No Abstract]   [Full Text] [Related]  

  • 40. [Moxifloxacin (Kanavig), ophthalmic administration].
    J Pharm Belg; 2012 Jun; (2):41-2. PubMed ID: 22978015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.